Search

everythinglearnresearchcommunity

for

Search:↓

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Iron deficiency might contribute to hair loss in women.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Adding L-glutamine to the diet of Hanwoo steers may boost their immune system and help them cope with heat.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

A man's health improved after treating his undiagnosed adrenal insufficiency, which caused fatigue and weight loss.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

The study aims to create a model to improve personalized and preventive health care.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The model and estimator can predict drug exposure in kidney transplant patients well.

Bariatric surgery patients need careful before and after surgery care for safety and long-term health.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

DM and AA may share a common cause.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Satoyoshi syndrome can cause eye problems like uveitis and retinal vein issues.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Low selenium levels can extend lifespan but worsen health issues.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A woman with lupus had muscle weakness due to kidney issues and was successfully treated with medication.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

JAK inhibitors show promise for treating various skin diseases.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.